Literature DB >> 12483726

Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.

Jun Hirose1, Lawrence M Ryan, Ikuko Masuda.   

Abstract

OBJECTIVE: Excess accumulation of extracellular inorganic pyrophosphate (ePPi) in aged human cartilage is crucial in calcium pyrophosphate dihydrate (CPPD) crystal formation in cartilage matrix. Two sources of ePPi are ePPi-generating ectoenzymes (NTPPPH) and extracellular transport of intracellular PPi by ANK. This study was undertaken to evaluate the role of NTPPPH and ANK in ePPi elaboration, by investigating expression of NTPPPH enzymes (cartilage intermediate-layer protein [CILP] and plasma cell membrane glycoprotein 1 [PC-1]) and ANK in human chondrocytes from osteoarthritic (OA) articular cartilage containing CPPD crystals and without crystals.
METHODS: Chondrocytes were harvested from knee cartilage at the time of arthroplasty (OA with CPPD crystals [CPPD], n = 8; OA without crystals [OA], n = 10). Normal adult human chondrocytes (n = 1) were used as a control. Chondrocytes were cultured with transforming growth factor beta1 (TGFbeta1), which stimulates ePPi elaboration, and/or insulin-like growth factor 1 (IGF-1), which inhibits ePPi elaboration. NTPPPH and ePPi were measured in the media at 48 hours. Media CILP, PC-1, and ANK were determined by dot-immunoblot analysis. Chondrocyte messenger RNA (mRNA) was extracted for reverse transcriptase-polymerase chain reaction to study expression of mRNA for CILP, PC-1, and ANK. NTPPPH and ANK mRNA and protein were also studied in fresh frozen cartilage.
RESULTS: Basal ePPi elaboration and NTPPPH activity in conditioned media from CPPD chondrocytes were elevated compared with normal chondrocytes, and tended to be higher compared with OA chondrocytes. Basal expression of mRNA for CILP (chondrocytes) and ANK (cartilage) was higher in both CPPD chondrocytes and CPPD cartilage extract than in OA or normal samples. PC-1 mRNA was less abundant in CPPD chondrocytes and cartilage extract than in OA chondrocytes and extract, although the difference was not significant. CILP, PC-1, and ANK protein levels were similar in CPPD, OA, and normal chondrocytes or cartilage extracts. Both CILP and ANK mRNA expression and ePPi elaboration were stimulated by TGFbeta1 and inhibited by IGF-1 in chondrocytes from all sources.
CONCLUSION: CILP and ANK mRNA expression correlates with chondrocyte ePPi accumulation around CPPD and OA chondrocytes, and all respond similarly to growth factor stimulation. These findings suggest that up-regulated CILP and ANK expression contributes to higher ePPi accumulation from CPPD crystal-forming cartilage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483726     DOI: 10.1002/art.10632

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  27 in total

1.  [Chondrocalcinosis. Clinical impact of intra-articular calcium phosphate crystals].

Authors:  M Fuerst
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

2.  Biochemical and genetic analysis of ANK in arthritis and bone disease.

Authors:  Kyle A Gurley; Richard J Reimer; David M Kingsley
Journal:  Am J Hum Genet       Date:  2006-10-16       Impact factor: 11.025

Review 3.  Genetics and mechanisms of crystal deposition in calcium pyrophosphate deposition disease.

Authors:  Florence W L Tsui
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

4.  Enhanced apoptotic and reduced protective response in chondrocytes following endoplasmic reticulum stress in osteoarthritic cartilage.

Authors:  Koji Takada; Jun Hirose; Kei Senba; Soichiro Yamabe; Yuichi Oike; Tomomi Gotoh; Hiroshi Mizuta
Journal:  Int J Exp Pathol       Date:  2011-02-05       Impact factor: 1.925

Review 5.  [Crystal arthropathies].

Authors:  M Fuerst; J Haybaeck; J Zustin; W Rüther
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

6.  Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Miwa Uzuki; Takashi Sawai; Lawrence M Ryan; Ann K Rosenthal; Ikuko Masuda
Journal:  J Rheumatol       Date:  2013-12-01       Impact factor: 4.666

Review 7.  Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy.

Authors:  Hang-Korng Ea; Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

8.  Investigation of calcium crystals in OA knees.

Authors:  Martin Fuerst; L Lammers; F Schäfer; O Niggemeyer; J Steinhagen; C H Lohmann; W Rüther
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 9.  Tissue engineering of articular cartilage with biomimetic zones.

Authors:  Travis J Klein; Jos Malda; Robert L Sah; Dietmar W Hutmacher
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

Review 10.  The Role of ANK in Calcium Pyrophosphate Deposition Disease.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Brittany Bettendorf; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.